XOMA XOMA Corporation Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

XOMA [NASD]

XOMA Corporation

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	0.10%	Shs Outstand	10.82M	Perf Week	-2.68%
Market Cap	210.09M	Forward P/E	-	EPS next Y	-0.56	Insider Trans	-	Shs Float	10.41M	Perf Month	5.61%
Income	-9.40M	PEG	-	EPS next Q	-0.21	Inst Own	63.10%	Short Float	6.62%	Perf Quarter	9.02%
Sales	10.50M	P/S	20.01	EPS this Y	85.80%	Inst Trans	2.39%	Short Ratio	21.17	Perf Half Y	-18.59%
Book/sh	3.55	P/B	5.52	EPS next Y	58.20%	ROA	-10.40%	Target Price	29.50	Perf Year	6.07%
Cash/sh	4.61	P/C	4.24	EPS next 5Y	19.00%	ROE	-25.30%	52W Range	14.14 - 28.85	Perf YTD	-28.28%
Dividend	-	P/FCF	-	EPS past 5Y	49.80%	ROI	-5.10%	52W High	-32.13%	Beta	0.91
Dividend %	-	Quick Ratio	4.60	Sales past 5Y	-0.50%	Gross Margin	-	52W Low	38.47%	ATR	1.17
Employees	11	Current Ratio	4.60	Sales Q/Q	-60.00%	Oper. Margin	-94.10%	RSI (14)	47.87	Volatility	6.51% 5.80%
Optionable	No	Debt/Eq	0.81	EPS Q/Q	30.10%	Profit Margin	-89.60%	Rel Volume	0.31	Prev Close	19.86
Shortable	Yes	LT Debt/Eq	0.61	Earnings	-	Payout	-	Avg Volume	32.56K	Price	19.58
Recom	2.00	SMA20	-0.57%	SMA50	0.47%	SMA200	-7.04%	Volume	10,182	Change	-1.41%

Jan-18-18

Reiterated

H.C. Wainwright

Buy

$38 → $49

Oct-17-17

Resumed

H.C. Wainwright

Buy

$38

Sep-05-17

Upgrade

Wedbush

Neutral → Outperform

$9 → $19

Jun-12-17

Initiated

H.C. Wainwright

Buy

$15

Nov-14-16

Downgrade

Wedbush

Outperform → Neutral

$17 → $14

Mar-11-16

Reiterated

Wedbush

Outperform

$6 → $3

Jul-23-15

Downgrade

Jefferies

Buy → Hold

Jul-22-15

Downgrade

Piper Jaffray

Overweight → Neutral

Jul-22-15

Downgrade

Ladenburg Thalmann

Buy → Neutral

Oct-10-14

Resumed

ROTH Capital

Buy

Apr-29-14

Upgrade

MLV & Co

Hold → Buy

Mar-11-14

Downgrade

MLV & Co

Buy → Hold

$8 → $7

Mar-05-14

Reiterated

Ladenburg Thalmann

Buy

$6.50 → $10

Oct-31-13

Reiterated

MLV & Co

Buy

$7.50 → $8

May-09-13

Reiterated

Ladenburg Thalmann

Buy

$5 → $6

May-14-12

Initiated

Cowen & Co

Outperform

Mar-31-11

Reiterated

MLV Capital

Buy

$12 → $10

Mar-23-11

Reiterated

RBC Capital Mkts

Outperform

$8 → $6

Jan-06-11

Reiterated

Ladenburg Thalmann

Buy

$12 → $16

Jan-04-11

Reiterated

Wedbush

Outperform

$12 → $16

Oct-14-20 07:30AM	XOMA Earns $1.9 Million Associated with Two Partner Developments GlobeNewswire
Sep-23-20 12:15PM	Is XOMA Corporation (NASDAQ:XOMA) Popular Amongst Institutions? Simply Wall St.
Sep-10-20 11:18AM	Insider Buys XOMA's Shares Benzinga
Sep-02-20 07:30AM	XOMA to Present at Upcoming Investor Conferences GlobeNewswire
Aug-17-20 07:19AM	XOMA's Shares March Higher, Can It Continue? Zacks
Aug-06-20 07:50PM	Xoma (XOMA) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM	XOMA Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-05-20 07:30AM	XOMA to Present at the 2020 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-28-20 12:33PM	Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-01-20 07:30AM	XOMA Announces Natasha Hernday Joins its Board of Directors GlobeNewswire
Jun-29-20 07:30AM	XOMA Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire -6.22%
Jun-24-20 11:00PM	XOMA (XOMA) Catches Eye: Stock Jumps 5.2% Zacks
Jun-22-20 01:58PM	Hedge Funds Are Souring On XOMA Corp (XOMA) Insider Monkey
May-11-20 01:42PM	Things Look Grim For XOMA Corporation (NASDAQ:XOMA) After Today's Downgrade Simply Wall St. +6.92%
May-05-20 09:45AM	Xoma (XOMA) Reports Q1 Loss, Lags Revenue Estimates Zacks
07:30AM	XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business Update GlobeNewswire
Apr-28-20 12:39PM	Health Check: How Prudently Does XOMA (NASDAQ:XOMA) Use Debt? Simply Wall St. +5.37%
Apr-27-20 12:31PM	Earnings Preview: Xoma (XOMA) Q1 Earnings Expected to Decline Zacks
Mar-13-20 10:53AM	Can You Imagine How Chuffed XOMA's (NASDAQ:XOMA) Shareholders Feel About Its 215% Share Price Gain? Simply Wall St. +11.81%
Mar-10-20 07:30AM	XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights GlobeNewswire -6.23%
Mar-09-20 05:00AM	Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement GlobeNewswire -5.74%
Feb-27-20 12:30PM	Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release Zacks
Feb-25-20 04:30PM	XOMA to Present at the Cowen and Company 40th Annual Health Care Conference GlobeNewswire
Jan-22-20 01:02PM	Before You Buy XOMA Corporation (NASDAQ:XOMA), Consider Its Volatility Simply Wall St.
Dec-26-19 07:12AM	Will XOMA Continue to Surge Higher? Zacks
Dec-23-19 04:00PM	Should You Avoid XOMA Corp (XOMA)? Insider Monkey +13.39%
Dec-20-19 04:35PM	XOMA Announces Closing of Rights Offering GlobeNewswire
Dec-16-19 09:34AM	5 Biotech Stocks Set for Continued Rally in 2020 Zacks
Dec-05-19 05:04PM	Iscalimab (CFZ533) Update GlobeNewswire
Dec-02-19 04:30PM	XOMA Announces Commencement of Rights Offering GlobeNewswire
Nov-19-19 04:30PM	XOMA Announces Proposed Rights Offering GlobeNewswire
Nov-13-19 06:47AM	Will XOMA Continue to Surge Higher? Zacks
Nov-05-19 08:20AM	XOMA Reports Third Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results GlobeNewswire +7.34%
Oct-30-19 10:33AM	Will Xoma (XOMA) Report Negative Q3 Earnings? What You Should Know Zacks
Oct-15-19 03:39PM	How Much Are XOMA Corporation (NASDAQ:XOMA) Insiders Spending On Buying Shares? Simply Wall St.
Sep-27-19 07:56AM	The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave Benzinga
Sep-26-19 04:07PM	XOMA Acquires Royalty Interest Position in Six Clinical-Stage Assets GlobeNewswire
08:27AM	XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-12-19 01:37PM	What Did XOMA Corporation's (NASDAQ:XOMA) CEO Take Home Last Year? Simply Wall St.
Sep-03-19 08:00AM	XOMA to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire
Aug-13-19 08:30AM	Health Check: How Prudently Does XOMA (NASDAQ:XOMA) Use Debt? Simply Wall St.
Aug-12-19 07:30AM	XOMAs Royalty Portfolio Expands Significantly GlobeNewswire
Aug-06-19 10:05AM	Xoma (XOMA) Reports Q2 Loss, Tops Revenue Estimates Zacks -5.72%
07:30AM	XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results GlobeNewswire
Jul-30-19 03:16PM	A Firm's First Profit Can Mean Big Returns for Investors Zacks
10:38AM	Analysts Estimate Xoma (XOMA) to Report a Decline in Earnings: What to Look Out for Zacks
06:30AM	XOMA to Present at the 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-09-19 02:07PM	What Kind Of Share Price Volatility Should You Expect For XOMA Corporation (NASDAQ:XOMA)? Simply Wall St.
Jun-13-19 06:45AM	First Patient Dosed with Gevokizumab in Collaborator Clinical Study in Metastatic Colorectal Cancer, Gastroesophageal Cancer, and Renal Cell Carcinoma GlobeNewswire
Jun-07-19 09:25AM	If You Had Bought XOMA (NASDAQ:XOMA) Stock Five Years Ago, You'd Be Sitting On A 81% Loss, Today Simply Wall St.
May-06-19 07:55PM	Xoma (XOMA) Surpasses Q1 Earnings and Revenue Estimates Zacks
06:43PM	Xoma: 1Q Earnings Snapshot Associated Press
04:30PM	XOMA Reports First Quarter 2019 Financial Results and Operating Highlights GlobeNewswire
May-01-19 10:33AM	Will Xoma (XOMA) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-12-19 05:20PM	Portland biotech inks $9M+ deal for drug royalties American City Business Journals
Apr-11-19 12:14PM	Is XOMA Corporation's (NASDAQ:XOMA) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Apr-08-19 06:00AM	XOMA Acquires Royalty Rights to Five Hematology Candidates GlobeNewswire
Apr-03-19 07:00AM	XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference GlobeNewswire +6.44%
Mar-07-19 07:05AM	XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights GlobeNewswire
Mar-05-19 07:00AM	XOMA to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-21-19 05:48PM	Stealth rally happening in value stocks, is the trend here to stay CNBC Videos
Feb-13-19 07:00AM	XOMA Receives $5.5 Million Payment from Rezolute GlobeNewswire +13.82%
Feb-04-19 07:28AM	How Much Are XOMA Corporation (NASDAQ:XOMA) Insiders Spending On Buying Shares? Simply Wall St.
Jan-03-19 04:35PM	XOMA Announces Barbara Kosacz Joins its Board of Directors GlobeNewswire
Dec-18-18 04:43PM	XOMA Announces Closing of Rights Offering GlobeNewswire
Nov-19-18 04:30PM	XOMA Announces Commencement of Rights Offering GlobeNewswire
Nov-07-18 11:55AM	Xoma (XOMA) Reports Q3 Loss, Tops Revenue Estimates Zacks +8.35%
10:52AM	Xoma: 3Q Earnings Snapshot Associated Press
07:05AM	XOMA Announces Proposed Rights Offering GlobeNewswire
07:00AM	XOMA Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-30-18 08:05AM	Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors GlobeNewswire
Oct-29-18 10:31AM	Xoma (XOMA) Q3 Earnings Preview: What's Shaping Up? Zacks
Oct-25-18 08:15AM	Analysis: Positioning to Benefit within Middlesex Water, On Deck Capital, New Relic, Toro, XOMA, and ESCO Technologies Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire -7.49%
Sep-27-18 04:30PM	XOMA to Present at the Cantor Fitzgerald Healthcare Conference 2018 and the 2018 BIO Investor Forum GlobeNewswire -6.07%
Sep-24-18 12:15PM	The XOMA Corporation (NASDAQ:XOMA) Ownership Structure Could Be Important Simply Wall St. +5.68%
Sep-21-18 07:00AM	XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte GlobeNewswire
Aug-28-18 07:00AM	XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference GlobeNewswire
Aug-09-18 07:00AM	XOMA to Present at the 2018 Wedbush PacGrow Healthcare Conference and the 2018 Southern California Investor Conference GlobeNewswire
Aug-07-18 06:15PM	Xoma (XOMA) Reports Q2 Loss, Lags Revenue Estimates Zacks
05:08PM	Xoma: 2Q Earnings Snapshot Associated Press
04:35PM	XOMA Reports Second Quarter 2018 Financial Results GlobeNewswire
07:40AM	Detailed Research: Economic Perspectives on Alleghany, Enable Midstream Partners, LP, XOMA, MCBC, Unifi, and Tyler Technologies What Drives Growth in Today's Competitive Landscape GlobeNewswire
Jun-26-18 07:00AM	XOMA Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire
May-15-18 07:00AM	XOMA to Present at the UBS Global Healthcare Conference GlobeNewswire
May-09-18 06:11PM	Xoma: 1Q Earnings Snapshot Associated Press
04:05PM	XOMA Reports First Quarter 2018 Financial Results GlobeNewswire
May-08-18 07:00AM	XOMA Announces $20 Million Credit Facility with Silicon Valley Bank to Advance Royalty-Aggregator Business Model GlobeNewswire
May-02-18 07:30AM	New Research: Key Drivers of Growth for HTG Molecular Diagnostics, Impinj, XOMA, Stock Yards, TriCo Bancshares, and Alleghany Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-03-18 07:00AM	XOMA to Present at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire +5.89%
Mar-20-18 07:35AM	Investor Expectations to Drive Momentum within Key Energy Services, XOMA, Goldman Sachs BDC, Echo Global Logistics, Ellington Residential Mortgage REIT, and Phibro Animal Health Discovering Underlying Factors of Influence GlobeNewswire
Mar-07-18 05:46PM	Xoma reports 4Q loss Associated Press +7.78%
04:05PM	XOMA Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update GlobeNewswire
Mar-05-18 07:00AM	XOMA to Present at the Cowen and Company 38th Annual Health Care Conference GlobeNewswire
Feb-19-18 10:04AM	AbbVie Presents New Data on Upadacitinib for Crohn's Disease Zacks
Feb-16-18 09:56AM	FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review Zacks
Feb-14-18 05:48PM	AVEO (AVEO) to Get $2 Million from EUSA Pharma for Fotivda Zacks
Feb-08-18 11:26AM	Theravance, J&J Ink Deal for Inflammatory Intestinal Drug Zacks
09:49AM	Keryx (KERX) Loss Wider Than Expected in Q4, Stock Down Zacks
Feb-06-18 10:00AM	Pfizer Files for Xtandi in Early Stage Prostate Cancer Zacks
Feb-02-18 10:00AM	Puma, CANbridge Team Up to Commercialize Nerlynx in China Zacks

XOMA Corporation, a biotech company, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include X213, an allosteric inhibitor of prolactin action; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; IL-2, a therapy for metastatic melanoma and renal cell carcinoma; and PTH1R, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy. The company also licenses antibody discovery, optimization, and development technologies. It has research and development collaboration agreements with Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; Rezolute, Inc.; and Takeda Pharmaceutical Company Limited. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BVF PARTNERS L P/IL	Director	Sep 23	Buy	18.20	17,089	311,016	2,040,124	Sep 23 07:26 PM
BVF PARTNERS L P/IL	Director	Sep 22	Buy	18.45	11,951	220,445	2,030,236	Sep 23 07:26 PM
BVF PARTNERS L P/IL	Director	Sep 21	Buy	18.39	22,328	410,503	2,023,276	Sep 23 07:26 PM
BVF PARTNERS L P/IL	Director	Sep 04	Buy	18.77	7,737	145,228	2,011,017	Sep 10 08:10 AM
BVF PARTNERS L P/IL	Director	Sep 01	Buy	18.87	17,572	331,515	2,007,110	Sep 01 08:37 PM
BVF PARTNERS L P/IL	Director	Aug 31	Buy	18.48	16,005	295,782	1,997,210	Sep 01 08:37 PM
BVF PARTNERS L P/IL	Director	Aug 28	Buy	19.17	2,044	39,187	1,988,067	Sep 01 08:37 PM
BVF PARTNERS L P/IL	Director	Aug 25	Buy	19.75	5,687	112,290	1,986,945	Aug 25 08:10 PM
BVF PARTNERS L P/IL	Director	Aug 24	Buy	19.31	11,683	225,591	1,983,502	Aug 25 08:10 PM
BVF PARTNERS L P/IL	Director	Aug 21	Buy	19.32	10,805	208,770	1,976,998	Aug 25 08:10 PM
BVF PARTNERS L P/IL	10% Owner	Aug 20	Buy	19.12	1,772	33,881	1,967,800	Aug 20 06:56 PM
BVF PARTNERS L P/IL	10% Owner	Aug 19	Buy	19.70	3,496	68,877	1,966,028	Aug 20 06:56 PM
BVF PARTNERS L P/IL	10% Owner	Aug 18	Buy	19.27	895	17,246	1,962,532	Aug 20 06:56 PM
BVF PARTNERS L P/IL	10% Owner	Aug 14	Buy	18.69	21,922	409,810	1,961,637	Aug 14 06:38 PM
BVF PARTNERS L P/IL	10% Owner	Aug 13	Buy	17.80	1,050	18,693	1,939,715	Aug 14 06:38 PM
BVF PARTNERS L P/IL	10% Owner	Aug 12	Buy	17.34	4,050	70,233	1,938,665	Aug 14 06:38 PM
BVF PARTNERS L P/IL	10% Owner	Mar 25	Buy	17.20	8,264	142,129	1,278,656	Mar 27 08:29 PM
Neal James R	CEO	Mar 23	Buy	14.50	1,000	14,500	20,849	Mar 24 04:38 PM
Neal James R	CEO	Mar 20	Buy	16.41	1,000	16,410	19,849	Mar 23 04:30 PM
BVF PARTNERS L P/IL	10% Owner	Mar 18	Buy	14.52	4,439	64,475	1,270,392	Mar 20 04:52 PM
BVF PARTNERS L P/IL	10% Owner	Mar 17	Buy	15.73	8,113	127,648	1,265,953	Mar 17 09:30 PM
BVF PARTNERS L P/IL	10% Owner	Mar 16	Buy	15.73	10,164	159,916	1,257,840	Mar 17 09:30 PM
BVF PARTNERS L P/IL	10% Owner	Mar 13	Buy	18.34	100,000	1,834,090	1,247,676	Mar 17 09:30 PM
BVF PARTNERS L P/IL	10% Owner	Dec 19	Buy	22.00	373,195	8,210,290	1,147,676	Dec 20 07:18 PM
Neal James R	CEO	Nov 06	Option Exercise	5.50	4,348	23,914	22,017	Nov 08 04:30 PM
Neal James R	CEO	Nov 06	Sale	22.00	4,348	95,656	17,669	Nov 08 04:30 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience